Catheter Ablation Versus Antiarrhythmic Drugs for Outflow Tract Ventricular ARrhythmias

Ospedale San Donato

Overview

A randomized, parallel, open study comparing catheter ablation versus antiarrhythmic drugs for outflow tract ventricular arrhythmias

Study Type

INTERVENTIONAL

Conditions

Ventricular Tachycardia Ventricular Premature Complexes

Interventions

antiarrhythmic drugs (Flecainide or Propafenone or Sotalol)DRUG

Catheter AblationPROCEDURE

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1\. presence of ventricular ectopic beats (VEB) with left-bundle-branch block morphology or right-bundle-branch block morphology and positive concordance throughout the chest leads, inferior axis and at least one of the following: 1. \>2000 isolated VEB/24h 2. symptomatic monomorphic ventricular tachycardia 3. left ventricular disfunction supposed to be due to tachycardia-induced cardiomyopathy Exclusion Criteria: 1. known structural heart disease 2. pregnancy 3. life expectancy \< 1 year

Locations (1)

Cardiovascular Department, Ospedale S.Donato

Arezzo, AR, Italy

RECRUITING

Outcomes

Primary Outcomes

SF-36 score

Quality of life improvement according to SF-36 score variations

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.